Clinical characteristics, management and psychological outcomes of patients with diabetes secondary to chronic pancreatitis
Philip C Johnston, Aaron Herron, Mark Davies, Mark Taylor, Glynis Magee, Ailish Nugent, Judith Garrity, Ian Wallace, Judith Thompson
{"title":"Clinical characteristics, management and psychological outcomes of patients with diabetes secondary to chronic pancreatitis","authors":"Philip C Johnston, Aaron Herron, Mark Davies, Mark Taylor, Glynis Magee, Ailish Nugent, Judith Garrity, Ian Wallace, Judith Thompson","doi":"10.1002/pdi.2501","DOIUrl":null,"url":null,"abstract":"Aims: To determine the clinical characteristics, management, rates of complications and psychological outcomes of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) referred to the Belfast Pancreatic Diabetes Clinic.Methods: Clinical and laboratory data were obtained from online health care records (NIECR). Psychological outcomes and a service‐based questionnaire were performed.Results: Baseline characteristics (n=63 patients [male: 41, female: 22]) at initial referral included: mean age 56.2 years (range 19–84); mean duration of chronic pancreatitis 10.7 years (range 1–40); mean duration of diabetes 7.2 years (range 1–40). Previous pancreatic surgery was performed in 19% (12/63) of patients. Initial mean HbA1c was 82mmol/mol (range 41–189); mean HbA1c at six and 12 months follow‐up was 69.9mmol/mol and 70.6mmol/mol, respectively. Rates of microvascular complications included: retinopathy (background and pre‐proliferative) 16%; microalbuminuria 17%; peripheral neuropathy 14%, with no foot ulceration/amputation occurring. Macrovascular disease occurred in 24% of patients. Sixteen (25%) had missed at least one outpatient diabetes appointment over the preceding year. Quality of life (QoL) as measured by the PANQOLI was low with a mean total score of 64.9/103; 59% (16/27) of the service cohort also breached clinical cut‐offs for the presence of both anxiety (GAD‐7) and depression (PHQ‐9).Summary: DMsCP in our cohort was characterised by significant micro‐ and macrovascular complications, sub‐optimal glycaemic control, reduced clinic attendance and impaired QoL as well as a significant component of anxiety and depression. The optimal care for these patients should consist of a collaborative approach that best meets their complex and multifaceted needs. Copyright © 2024 John Wiley & Sons.","PeriodicalId":0,"journal":{"name":"","volume":"62 s288","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pdi.2501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
慢性胰腺炎继发糖尿病患者的临床特征、管理和心理结果
目的:确定转诊至贝尔法斯特胰腺糖尿病诊所的慢性胰腺炎继发性糖尿病(DMsCP)患者的临床特征、管理、并发症发生率和心理结果:临床和实验室数据来自在线医疗记录(NIECR)。结果:基线特征(63 名患者)(n=63)和心理结果(n=63):首次转诊时的基线特征(63 名患者,男性 41 名,女性 22 名)包括:平均年龄 56.2 岁(19-84 岁不等);慢性胰腺炎平均病程 10.7 年(1-40 年不等);糖尿病平均病程 7.2 年(1-40 年不等)。19%的患者(12/63)曾接受过胰腺手术。初始平均 HbA1c 为 82mmol/mol(范围 41-189);随访 6 个月和 12 个月时的平均 HbA1c 分别为 69.9mmol/mol 和 70.6mmol/mol。微血管并发症的发生率包括:视网膜病变(背景和增殖前)16%;微量白蛋白尿 17%;周围神经病变 14%,没有发生足部溃疡/截肢。24%的患者患有大血管疾病。16名患者(25%)在过去一年中至少错过了一次糖尿病门诊预约。根据 PANQOLI 测量,患者的生活质量(QoL)较低,平均总分为 64.9/103;59%(16/27)的患者还超过了焦虑症(GAD-7)和抑郁症(PHQ-9)的临床临界值。对这些患者的最佳治疗应包括一种协作方法,以最好地满足他们复杂和多方面的需求。版权所有 © 2024 约翰威利父子公司。
本文章由计算机程序翻译,如有差异,请以英文原文为准。